Cargando…

Association between clinicopathologic characteristics and BRAF(V600E) expression in Chinese patients with Langerhans cell histiocytosis

BACKGROUND: The identification of V‐raf murine sarcoma viral oncogene homolog B1 (BRAF)(V600E) mutations has been recommended in patients with Langerhans cell histiocytosis (LCH) with difficult diagnosis and failure of first‐line treatment. The reported frequencies of BRAF(V600E) mutations vary in C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hui, Lu, Tao, Sun, Yuxin, Li, Shan, Li, Ji, Xu, Kai, Feng, Rui e, Xu, Zuo jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775012/ https://www.ncbi.nlm.nih.gov/pubmed/31441596 http://dx.doi.org/10.1111/1759-7714.13179

Ejemplares similares

Clinicopathological features and BRAF(V600E) mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis
por: Huo, Zhen, et al.
Publicado: (2016)

BRAF V600E-Positive Congenital Multisite Langerhans Cell Histiocytosis
por: Prada Avella, Maria Camila, et al.
Publicado: (2020)

Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF(V600E)-Mutated Langerhans Cell Histiocytosis
por: Yang, Ying, et al.
Publicado: (2021)

A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
por: Phan, Thu Dang Anh, et al.
Publicado: (2021)

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate
por: Bates, Sara V., et al.
Publicado: (2013)

Lineage switching of the cellular distribution of BRAF(V600E) in multisystem Langerhans cell histiocytosis
por: Milne, Paul, et al.
Publicado: (2022)

Langerhans Cell Histiocytosis, Non-Langerhans histiocytosis and concurrent Papillary Thyroid Carcinoma with BRAF V600E mutations: A case report and literature review
por: Wake, Laura, et al.
Publicado: (2019)

Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020)

BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay
por: Tatsuno, Michiko, et al.
Publicado: (2016)

Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?
por: Moschovi, Maria, et al.
Publicado: (2015)

Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF(V600E)
por: Milne, Paul, et al.
Publicado: (2022)

Dabrafenib, alone or in combination with trametinib, in BRAF V600–mutated pediatric Langerhans cell histiocytosis
por: Whitlock, James A., et al.
Publicado: (2023)

BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis
por: Nelson, David S., et al.
Publicado: (2019)

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
por: Kudo, Ko, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation for efficient treatment of multisystem, high-risk, BRAF V600E-negative Langerhans cell histiocytosis
por: Pan, Yaozhu, et al.
Publicado: (2019)

BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis
por: Zeng, Kaixuan, et al.
Publicado: (2016)

Adult Onset of BRAF(V600E)-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining
por: Tono, Hisayuki, et al.
Publicado: (2015)

Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAF(V600E) mutations in adult populations
por: Selway, Joanne Louise, et al.
Publicado: (2017)

Multisystemic Pediatric Langerhans cell histiocytosis: a comprehensive clinico-pathological and BRAF V600E mutation study at autopsy
por: Kapatia, Gargi, et al.
Publicado: (2020)

Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing
por: Feng, Shunqiao, et al.
Publicado: (2021)

New somatic BRAF splicing mutation in Langerhans cell histiocytosis
por: Héritier, Sébastien, et al.
Publicado: (2017)

Impact of BRAF(V600E) mutation on aggressiveness and outcomes in adult clonal histiocytosis
por: Razanamahery, Jerome, et al.
Publicado: (2023)

Three decades of progress from surgery to medical therapy for isolated neuroaxis BRAF V600E–positive Langerhans cell histiocytosis management: illustrative case
por: Muthiah, Nallammai, et al.
Publicado: (2021)

A Risk Model Composed of Complete Blood Count, BRAF V600E and MAP2K1 Predicts Inferior Prognosis of Langerhans Cell Histiocytosis in Children
por: Wang, Leyuan, et al.
Publicado: (2022)

BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
por: Soria, Xavier, et al.
Publicado: (2021)

Apparent Lack of BRAF(V600E) Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8(+) T Cells in Langerhans Cell Histiocytosis
por: Kemps, Paul G., et al.
Publicado: (2020)

Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011)

Langerhans cell histiocytosis
por: Kumar, Manish, et al.
Publicado: (2018)

BRAF Mutation Analysis in Two Cases of Congenital Self-Healing Langerhans Cell Histiocytosis
por: Takayama, Saki, et al.
Publicado: (2022)

Case series of cutaneous Langerhans cell histiocytosis in Indonesian children; The clinicopathological spectrum
por: Widodo, Irianiwati, et al.
Publicado: (2020)

Multisystem Langerhans Cell Histiocytosis in an infant
por: Ji, William, et al.
Publicado: (2021)

Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis
por: Tóth, Béla, et al.
Publicado: (2020)

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation
por: Holst, Johanne Marie, et al.
Publicado: (2021)

BRAF- and MAP2K1-Negative Multisystem Langerhans Cell Histiocytosis in an Elderly Patient
por: Kothari, Rohit, et al.
Publicado: (2023)

Langerhans cell histiocytosis of the sternum
por: Tsuchie, Hiroyuki, et al.
Publicado: (2009)

Pulmonary langerhans cell histiocytosis
por: Suri, Harpreet S, et al.
Publicado: (2012)

Langerhans cell histiocytosis of the sacrum
por: Hatem, M.A.
Publicado: (2015)

Langerhans cell histiocytosis of the bone
por: Huang, Wen-Chih, et al.
Publicado: (2017)

Langerhans Cell Histiocytosis of the Tonsil
por: Cipolla, Federica, et al.
Publicado: (2022)

Langerhans Cell Histiocytosis of the Mandible
por: Padmanaban, Kamalakannan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ps3hqdd3ccl33l76tjejbh5pdv